Vanquish Oncology
Vanquish Oncology is a biotechnology company that develops targeted, small-molecule oncology therapeutics for unmet or underserved cancer markets. It features an advanced program in selectively triggering cancer cell death through activating procaspase 3, a key late-stage effector of apoptosis. The company was founded in 2011 and headquartered in Champaign, Illinois.
Domain
vanquishoncology.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$1.0M
Founded
2010
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does Vanquish Oncology use?+
Vanquish Oncology uses 8 technologies including Twenty Twelve, WordPress, jQuery.
What industry is Vanquish Oncology in?+
Vanquish Oncology operates in the Biotechnology industry.
Where is Vanquish Oncology based?+
Vanquish Oncology is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026